Bruker Corp [BRKR] stock is trading at $54.46, up 3.77%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The BRKR shares have gain 13.20% over the last week, with a monthly amount glided 20.06%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Bruker Corp [NASDAQ: BRKR] stock has seen the most recent analyst activity on December 10, 2025, when Wolfe Research upgraded its rating to a Outperform but kept the price target unchanged to $60 for it. Previously, Goldman started tracking the stock with Sell rating on December 09, 2025, and set its price target to $40. On November 20, 2025, Rothschild & Co Redburn initiated with a Buy rating and assigned a price target of $60 on the stock. Citigroup downgraded its rating to a Neutral but stick to its price target of $40 on May 22, 2025. Guggenheim initiated its recommendation with a Buy and recommended $72 as its price target on December 19, 2024. UBS started tracking with a Neutral rating for this stock on December 10, 2024, and assigned it a price target of $66. In a note dated December 05, 2024, Goldman upgraded an Neutral rating on this stock but restated the target price of $60.
Bruker Corp [BRKR] stock has fluctuated between $28.53 and $64.64 over the past year. Currently, Wall Street analysts expect the stock to reach $51.78 within the next 12 months. Bruker Corp [NASDAQ: BRKR] shares were valued at $54.46 at the most recent close of the market. An investor can expect a potential drop of -4.92% based on the average BRKR price forecast.
Analyzing the BRKR fundamentals
Bruker Corp [NASDAQ:BRKR] reported sales of 3.44B for the trailing twelve months, which represents a drop of -0.45%. Gross Profit Margin for this corporation currently stands at 0.47% with Operating Profit Margin at 0.05%, Pretax Profit Margin comes in at 0.0%, and Net Profit Margin reading is -0.01%. To continue investigating profitability, this company’s Return on Assets is posted at -0.0, Equity is -0.01 and Total Capital is 0.04. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.84.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
For context, Bruker Corp’s Current Ratio is 1.85. As well, the Quick Ratio is 0.91, while the Cash Ratio is 0.23. Considering the valuation of this stock, the price to sales ratio is 2.32, the price to book ratio is 3.39.
Transactions by insiders
Recent insider trading involved Munch Mark, EXEC VP&PRES BRUKER NANO INC., that happened on Jan 05 ’26 when 33843.0 shares were sold. Officer, MARK R MUNCH completed a deal on Jan 05 ’26 to buy 33843.0 shares. Meanwhile, Director PACKER RICHARD A sold 5028.0 shares on Dec 01 ’25.
